Pfizer invests in enough solar energy to offset all North American operations

Developer Vesper Energy has announced that Pfizer has entered into a virtual power purchase agreement (VPPA) with the company. Under the 15-year agreement, Vesper will supply at least 310 MW of renewable energy to the grid, supplying 100% of the projected power needs of Pfizer’s North American operations with clean solar energy.

“We are proud to partner with Pfizer as it takes an important step in reducing the carbon footprint of its North American operations and achieving carbon neutrality,” said Craig Carson, CEO of Vesper Energy. “Vesper’s Hornet Solar project is a strong example of how we are putting high-performance renewable infrastructure to work solving our customers’ energy challenges while making a meaningful contribution to the larger sustainability movement.”

The solar power will be generated from Vesper’s 500 MW Hornet Solar project in western Texas, which will be fully operational by the end of 2023.

“At Pfizer, we apply science to the world’s biggest health challenges, and that commitment extends to confronting climate change, which has profound implications for society and public health,” said Bill Carapezzi, executive VP of Global Business Services and Transformation at Pfizer. “We are delighted to enter into this virtual power purchase agreement, which is an important step towards achieving our 2030 target of sourcing 100% renewable energy.”

News item from Vesper Energy

Comments are closed.